iwCLL 2019 | What’s next for CLL treatment?

Thomas Kipps

Thomas Kipps, MD, PhD, UC San Diego, Moores Cancer Center, La Jolla, CA discusses the next steps in chronic lymphocytic leukemia (CLL) therapies and voices concerns on resistance to new treatments. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video